MLKL and neoplasm: Furthermore, scientists from VIB-UGent Center for Medical Biotechnology have made significant progress by inducing the production of MLKL protein in cancer cells, promoting necroptosis in tumor cells, and triggering recognition by the immune system (van Hoecke et al., 2018).